U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 9 of 9 results

Status:
US Approved Rx (2014)
First approved in 2014

Class (Stereo):
CHEMICAL (ABSOLUTE)



Tedizolid (also known as TR-700, DA-7157) as is an active compound, which is produced by plasma or intestinal phosphatases, after administration of the drug, tedizolid phosphate either orally or intravenously. The mechanism of action of tedizolid occ...
Status:
US Approved Rx (2021)
First approved in 2014

Class (Stereo):
CHEMICAL (ABSOLUTE)



Oritavancin is an glycopeptide antibiotic with bactericidal activity effective in treating infections caused by Gram-positive organisms. It treats complicated skin and skin structure infections. This drug demonstrates similar activity to vancomycin, ...
Status:
US Approved Rx (2013)
First approved in 2009

Class (Stereo):
CHEMICAL (ABSOLUTE)


TELAVANCIN (VIBATIV®) is a lipoglycopeptide antibacterial that is a synthetic derivative of vancomycin. It exerts concentration-dependent, bactericidal activity against Gram-positive organisms in vitro. TELAVANCIN (VIBATIV®) inhibits cell wall biosyn...
Status:
US Approved Rx (2016)
First approved in 1958

Class (Stereo):
CHEMICAL (ABSOLUTE)



Vancomycin is a branched tricyclic glycosylated nonribosomal peptide produced by the fermentation of the Actinobacteria species Amycolatopsis orientalis (formerly Nocardia orientalis). Vancomycin became available for clinical use >50 years ago. It...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Ridinilazole (SMT19969) is a compound that was developed as a treatment for Clostridium difficile infection, which is a spore-forming bacterial infection and the leading cause of infectious healthcare-associated diarrhea. Ridinilazole has a highly ta...
mixture
Status:
US Approved Rx (2014)
First approved in 2014

Class:
MIXTURE



Dalbavancin is a second-generation lipoglycopeptide antibiotic that was designed to improve on the natural glycopeptides currently available, such as vancomycin and teicoplanin. Modifications from these older glycoprotein classes allowed a similar me...
structurally diverse
Status:
Investigational

Class:
STRUCTURALLY DIVERSE

Status:
US Approved Rx (2016)
First approved in 1958

Class (Stereo):
CHEMICAL (ABSOLUTE)



Vancomycin is a branched tricyclic glycosylated nonribosomal peptide produced by the fermentation of the Actinobacteria species Amycolatopsis orientalis (formerly Nocardia orientalis). Vancomycin became available for clinical use >50 years ago. It...